4Scheistroen M, Trope C, Kaern J, et al. Malignant Melanoma of Vulva FIGO Stage I: Evaluation of Prognostic Factors in 43Patients With Emphasis on DNA Ploidy and Surgical Treatment [J]. Gynecol Oncol, 1996, 61: 253
5Dennis J, Buchanan MD, John Schlaerth MD, et al. Primary vaginal melanoma Thirteen-year disease-free survival after wide local excision and review of recent literature[J]. Am Obstet Gynecol, 1998, 178:1177
6Haffner AC, Garbe C, Buttner P, et al. The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients[J]. Br J Cancer, 1992, 66:856
7Phillips GL, Bundy BN, Okagaki T, et al. Malignant melanoma of the vulva treated by radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group[J] .Cancer, 1994, 73:2626
8Trimble EL; Lewis JL, Williams LL, et al. Management of vular melanoma[J]. Gynecol Oncol, 1992, 45: 254
9Barth A, morton DL. Therapy in melanoma management[J] .Cancer, 1995, 75:726
10John P, Geisler MD, Katherune Y, et al. Pevic Exenteration for mglignant melanomas of the vogina or urithra with over 3 mm of invasion [J]. Gyneco Oncol, 1995, 59: 338
5Chung AF, Casey MJ, Flangnery JT, et al. Malignant melanoma of the vagina: report of 19 case. Obster Gynecol,1980,55 : 720-727.
6Ragnarsson-Olding B, Johansson H, Rutqvist LE. Malignant melanoma of the vagina and vagina. Trends in incidence, agedistribution, and long- term survivalamong 245 consecutive cases in sweden in 1960-1984. Cancer,1993,71 : 183-1897.
7Boragjani G, Prem KA, Okagahi T,et al. Primary Malignant melanoma of the vaginag: a clinicopathologieal analysis of 10 cases. Gynecal Oncol, 1990,37: 264-267.
